← Eichor
Condition: Substance Related Disorders Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Substance Related Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

tDCS to Decrease Opioid Relapse (UH3)
NA · 1 location(s) · Butler Hospital · NCT06432465Better Options for Chronic Cancer Pain
Phase 4 · 2 location(s) · VA Office of Research and Development · NCT06574009Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
NA · 11 location(s) · Pharmicell Co., Ltd. · NCT05093881Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
Phase 2 · 1 location(s) · Johns Hopkins University · NCT05145764Semaglutide for Helping Opioid Recovery
Phase 2 · 1 location(s) · Brigham and Women's Hospital · NCT06639464Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
NA · 1 location(s) · National Institute on Drug Abuse (NIDA) · NCT01036581Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07318480Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
NA · 1 location(s) · University of Minnesota · NCT05062369Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
NA · 1 location(s) · Emory University · NCT05711056tDCS Plus Varenicline for Smoking Cessation
Phase 4 · 1 location(s) · Centre for Addiction and Mental Health · NCT06798324Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
Phase N/A · 1 location(s) · National Institute on Drug Abuse (NIDA) · NCT06552741Modulation of THC Effects by CBD: a Dose-ranging Study
Phase 1/Phase 2 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT06099379Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
Phase 1 · 1 location(s) · University of Minnesota · NCT07158853iPAWS: Improving Pain Management After Wisdom Tooth Extraction Surgery
NA · 1 location(s) · Brown University · NCT07731295Reducing Blood Pressure in Mid-life Adult Binge Drinkers
NA · 1 location(s) · The University of Texas at Arlington · NCT05522075Evaluating a One-Year Version of the Parent-Child Assistance Program
NA · 2 location(s) · University of Oklahoma · NCT06163651Social Cognition in Severe Alcohol Use Disorder
NA · 1 location(s) · CHU de Reims · NCT07464613MIVetsCan: Can-Coach Trial (Phase 2)
NA · 1 location(s) · University of Michigan · NCT06283862Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Quitting Matters Human Immunodeficiency Virus Hybrid Trial
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06883097Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191Translation and Validation of the COMM and ASI-SR
Phase N/A · 1 location(s) · Uppsala University · NCT06084520AvertD Post-Approval Study
Phase N/A · 1 location(s) · Prescient Medicine Holdings, Inc. · NCT07135323BREATHE Free: a Pilot Feasibility Trial
NA · 1 location(s) · Augusta University · NCT06862050Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Phase N/A · 1 location(s) · BioDelivery Sciences International · NCT03720613The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette Reduction
Phase 2 · 1 location(s) · VapeAway · NCT07322432Effects of Ketogenic Diet on Alcohol Intoxication
NA · 1 location(s) · University of Pennsylvania · NCT07602270LGG Supplementation in Patients With AUD and ALD
Phase 2 · 1 location(s) · University of Louisville · NCT05178069In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
NA · 1 location(s) · University Hospital, Rouen · NCT03371641Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
Phase 2 · 1 location(s) · NYU Langone Health · NCT03667846
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.